Advocacy intelligence hub — real-time data for patient organizations
Coartem: FDA approved
Treatment of malaria in patients of 5 kg bodyweight or above with acute, uncomplicated malaria due to Plasmodium falciparum or mixed infections including P. falciparum
Salagen: FDA approved
Treatment of symptoms of xerostomia from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs2
Coartem
Novartis Pharmaceuticals
Salagen
MGI Pharma, Inc.
Browse all Recurrent Neisseria infections due to factor D deficiency news →
View all Recurrent Neisseria infections due to factor D deficiency specialists →